Common Side Effects Patients Report with Vascepa
Vascepa (icosapent ethyl), used to lower triglycerides and reduce cardiovascular risk, most often causes mild issues like joint pain, swelling in hands or feet from fluid retention, and constipation. These affect 3-5% of patients in trials, resolving without stopping treatment in most cases.[1]
What Serious Risks Do Doctors Warn About?
The main serious concern is atrial fibrillation or flutter, seen in 5% of Vascepa users versus 3.9% on placebo in the REDUCE-IT trial, sometimes leading to hospitalization. Bleeding risk also rises slightly (2.7% vs 2.1% placebo), particularly with blood thinners like aspirin. No increase in hemorrhagic stroke occurred.[1][2]
How Often Do These Effects Happen?
In the pivotal REDUCE-IT study of 8,179 high-risk patients:
- Joint pain: 2.3% (vs 1.8% placebo)
- Gout: 1.7% (vs 1.2%)
- Atrial fibrillation: 5.3% (vs 3.9%)
- Bleeding events: 2.7% (vs 2.1%)
Gastrointestinal upset like diarrhea or nausea is less common, under 2%.[2]
Why Might Some Patients Experience Muscle Pain or Rash?
Muscle pain (arthralgia) links to Vascepa's anti-inflammatory effects on EPA metabolism, while rash or allergic reactions are rare (<1%) and may signal sensitivity to the capsule's gelatin. Patients on statins report higher rates when combined.[1]
Differences from Lovaza or Fish Oil
Unlike mixed EPA/DHA fish oils like Lovaza, Vascepa's pure EPA profile cuts some GI issues but raises AFib risk more. No LDL cholesterol increase occurs, unlike some alternatives.3
When Should You Contact a Doctor?
Seek care for chest pain, irregular heartbeat, severe bleeding, or unexplained swelling. Most effects are manageable with dose adjustments or monitoring.[1]
[1]: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202057s019lbl.pdf
[2]: https://www.nejm.org/doi/full/10.1056/NEJMoa1812792